Conference Correspondents

Pembrolizumab in Advanced Soft-Tissue Sarcomas (STS)

CTOS 2016

Targeting the PD-1 pathway has changed the therapeutic landscape of several solid tumors and hematologic malignancies. This study, SARC 028, evaluated the safety and efficacy of pembrolizumab in patients with advanced soft-tissue sarcoma (STS) and bone sarcomas. In this phase [ Read More ]

AOPM 2016 Workshop Overview

AOPM 2016

On September 29, 2016, a diverse, multidisciplinary panel of experts convened in Washington, DC, to discuss current challenges and potential solutions in oncology practice management. This summary represents an overview of the top 5 areas of discussion at the workshop. [ Read More ]

Trabectedin Approved for Use in Uterine Leiomyosarcoma

CTOS 2016

In this interview, Martee Hensley, MD, a medical oncologist practicing at Memorial Sloan Kettering Cancer Center, commented on the introduction of trabectedin as a treatment alternative for women with uterine leiomyosarcoma. Dr Hensley described that trabectedin is approved by the [ Read More ]